Cargando…
Testosterone deficiency and cardiovascular mortality
New concerns have been raised regarding cardiovascular (CV) risks with testosterone (T) therapy (TTh). These concerns are based primarily on two widely reported retrospective studies. However, methodological flaws and data errors invalidate both studies as credible evidence of risk. One showed reduc...
Autor principal: | Morgentaler, Abraham |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4291871/ https://www.ncbi.nlm.nih.gov/pubmed/25432501 http://dx.doi.org/10.4103/1008-682X.143248 |
Ejemplares similares
-
Testosterone therapy in men with prostate cancer: literature review, clinical experience, and recommendations
por: Morgentaler, Abraham, et al.
Publicado: (2015) -
Nerve growth factor as a new treatment for testosterone deficiency?
por: Morgentaler, Abraham
Publicado: (2018) -
Controversies in testosterone replacement therapy: testosterone and cardiovascular disease
por: Hwang, Kathleen, et al.
Publicado: (2015) -
Diagnosis and management of testosterone deficiency
por: McBride, James A, et al.
Publicado: (2015) -
Testosterone deficiency: a historical perspective
por: Nieschlag, Eberhard, et al.
Publicado: (2014)